Search

Author/Creator Nagashima, Tamon

1. Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study. Issue 3 (10th December 2019)

Authors:
Hatanaka, Takeshi; Kakizaki, Satoru; Nagashima, Tamon; Namikawa, Masashi; Tojima, Hiroki; Shimada, Yasushi; Takizawa, Daichi; Naganuma, Atsushi; Arai, Hirotaka; Sato, Ken; Harimoto, Norifumi; Shirabe, Ken; Uraoka, Toshio
Journal:
Hepatology research
Issue:
Volume 50:Issue 3(2020)
Page Start:
382
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin. Issue 3 (25th September 2017)

Authors:
Sato, Ken; Naganuma, Atsushi; Nagashima, Tamon; Hoshino, Takashi; Uehara, Daisuke; Arai, Yousuke; Horiuchi, Katsuhiko; Yuasa, Kazuhisa; Takayama, Hisashi; Arai, Hirotaka; Hatanaka, Takeshi; Ohyama, Tatsuya; Tahara, Hiroki; Sohara, Naondo; Kobayashi, Takeshi; Horiguchi, Norio; Yamazaki, Yuichi; Ka...
Journal:
Hepatology research
Issue:
Volume 48:Issue 3(2018)
Page Start:
E347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Favorable outcome of retreatment by direct‐acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure. Issue 3 (19th December 2019)

Authors:
Tojima, Hiroki; Kakizaki, Satoru; Takakusagi, Satoshi; Hoshino, Takashi; Naganuma, Atsushi; Nagashima, Tamon; Namikawa, Masashi; Ueno, Takashi; Shimada, Yasushi; Hatanaka, Takeshi; Takizawa, Daichi; Arai, Hirotaka; Sato, Ken; Takagi, Hitoshi; Uraoka, Toshio
Journal:
Hepatology research
Issue:
Volume 50:Issue 3(2020)
Page Start:
303
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression. Issue 8 (5th May 2021)

Authors:
Hiraoka, Atsushi; Kumada, Takashi; Hatanaka, Takeshi; Tada, Toshifumi; Kariyama, Kazuya; Tani, Joji; Fukunishi, Shinya; Atsukawa, Masanori; Hirooka, Masashi; Tsuji, Kunihiko; Ishikawa, Toru; Takaguchi, Koichi; Itobayashi, Ei; Tajiri, Kazuto; Shimada, Noritomo; Shibata, Hiroshi; Ochi, Hironori; Ka...
Journal:
Hepatology research
Issue:
Volume 51:Issue 8(2021)
Page Start:
880
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search